abstract |
The invention discloses Bruton tyrosine kinase inhibitors, and particularly relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation method thereof, a pharmaceutical composition containing the compound, and use of the compound in treatment of Bruton tyrosine kinase related diseases. |